SEARCH

Search Details
Last Updated :2026/06/12



Psychiatry
Lecturer

Research activity information

■ Paper
  • Machine-learning evaluation of driving performance in schizophrenia: A pilot study with short-duration driving simulator tasks
    Koichi Fujiwara; Shuji Tsunoda; Seiko Miyata; Akiko Yamaguchi; Shogo Kitagawa; Yuki Konishi; Reiji Yoshimura; Isao Taguchi; Yutaka Sawa; Kunihiro Iwamoto; Norio Ozaki
    TRANSPORTATION RESEARCH INTERDISCIPLINARY PERSPECTIVES, Mar. 2026
  • Evaluating and Determining the Effects of Psychotropic Drugs on Motor Vehicle Driving Performance: Key Considerations of the Japanese Guideline and Criteria for Clinical Implementation of Evidence.
    Tetsuo Nakabayashi; Kunihiro Iwamoto; Akiko Yamaguchi; Yuki Konishi; Momoe Saji; Reiji Yoshimura; Kousuke Kanemoto; Hirofumi Aoki; Masahiko Ando; Norio Ozaki
    Neuropsychopharmacology reports, Mar. 2026
  • 【うつ病123のQ&A】(第VIII部)うつ病の補完・代替医療,予防,社会的な取り組み 勤労者のうつ病が発生した場合,元の職場に戻らせるほうが良いのでしょうか?それとも新たに職場を探してもらうほうが良いのでしょうか?
    小西 勇輝
    精神科治療学, Oct. 2025
  • 【薬物療法を上手く行うためのちょっとしたコツ】向精神薬による性機能障害とその対応 臨床現場での実践的アプローチ
    小西 勇輝
    臨床精神薬理, Jul. 2025
  • 【精神疾患患者の就労・復職を支援する】気分障害を抱える労働者への休職・復職支援の現状と課題
    小西 勇輝
    精神医学, Mar. 2025
  • Protocol for a Survey on the Impact of Caring for a Relative With Dementia on Caregivers' Health and Work Functioning.
    Atsuko Ikenouchi; Yoshihisa Fujino; Tomomi Matsumoto; Naomichi Okamoto; Shinsuke Hamada; Shogo Kitagawa; Shunya Maruyama; Yuki Konishi; Hisashi Eguchi; Reiji Yoshimura
    Journal of UOEH, 2025
  • Effects of frequently prescribed antiseizure medications on motor vehicle driving performance: Narrative review based on a tiered approach for the assessment of clinically meaningful driving impairment in the Ministry of Health, Labour, and Welfare guideline.
    Kunihiro Iwamoto; Tetsuo Nakabayashi; Akiko Yamaguchi; Yuki Konishi; Momoe Saji; Reiji Yoshimura; Kousuke Kanemoto; Hirofumi Aoki; Masahiko Ando; Norio Ozaki
    Neuropsychopharmacology reports, Dec. 2024
  • Low-dose lamotrigine induces Pisa syndrome in a patient with probable corticobasal degeneration despite previous use.
    Naomichi Okamoto; Takahiro Sakakibara; Nagiho Tsukada; Enkhmurun Chibaatar; Gaku Hayasaki; Yuki Konishi; Atsuko Ikenouchi; Reiji Yoshimura
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Nov. 2024
  • Guideline for evaluating the effects of psychotropic drugs on motor vehicle driving performance in Japan: A tiered approach for the assessment of clinically meaningful driving impairment.
    Tetsuo Nakabayashi; Kunihiro Iwamoto; Akiko Yamaguchi; Yuki Konishi; Momoe Saji; Reiji Yoshimura; Kousuke Kanemoto; Hirofumi Aoki; Masahiko Ando; Norio Ozaki
    Neuropsychopharmacology reports, Jun. 2024
  • Oromandibular Dystonia After Low-Dose Olanzapine Treatment in a Patient With Marchiafava-Bignami Disease With Demyelinating Lesions in the Corpus Callosum: A Case Report.
    Nagiho Tsukada; Naomichi Okamoto; Yuki Konishi; Atsuko Ikenouchi; Reiji Yoshimura
    Cureus, Jan. 2024
  • Association between salivary mature brain-derived neurotrophic factor and psychological distress in healthcare workers.
    Atsuko Ikenouchi; Naomichi Okamoto; Shinsuke Hamada; Enkhmurun Chibaatar; Rintaro Fujii; Yuki Konishi; Ryohei Igata; Hirofumi Tesen; Reiji Yoshimura
    Brain and behavior, Dec. 2023
  • The new guideline for evaluating effects of psychotropic drugs on the performance to drive a motor vehicle in Japan: Comparison with US FDA guideline.
    Kunihiro Iwamoto; Tetsuo Nakabayashi; Akiko Yamaguchi; Yuki Konishi; Momoe Saji; Reiji Yoshimura; Kousuke Kanemoto; Hirofumi Aoki; Masahiko Ando; Norio Ozaki
    Neuropsychopharmacology reports, Jun. 2023
  • Acute pancreatitis during valproic acid administration in a patient with vascular dementia, epileptic seizures, and psychiatric symptoms: a case report.
    Mako Yanaga; Naomichi Okamoto; Reia Hashimoto; Ryohei Igata; Yuki Konishi; Atsuko Ikenouchi; Naoki Isomoto; Takahiro Shinkai; Masaru Harada; Reiji Yoshimura
    Journal of medical case reports, May 2023
  • A case of exploding head syndrome preceding the onset of mild cognitive impairment with Lewy bodies.
    Shogo Kitagawa; Naomichi Okamoto; Atsuko Ikenouchi; Ryohei Igata; Reia Hashimoto; Yuki Konishi; Hirofumi Tesen; Reiji Yoshimura
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Mar. 2023
  • Comparison of Serum Metabolomics Pathways and Patterns between Patients with Major Depressive Disorder with and without Type 2 Diabetes Mellitus: An Exploratory Study.
    Naomichi Okamoto; Takashi Hoshikawa; Atsuko Ikenouchi; Tomoya Natsuyama; Rintaro Fujii; Ryohei Igata; Hirofumi Tesen; Yuki Konishi; Yuichi Honma; Masaru Harada; Reiji Yoshimura
    Journal of integrative neuroscience, Jan. 2023
  • Mania after long-term treatment with daily 10 mg prednisolone.
    Rintaro Fujii; Yuki Konishi; Ryutaro Furusawa; Naomichi Okamoto; Reiji Yoshimura
    PCN reports : psychiatry and clinical neurosciences, Dec. 2022
  • 【よく目にする向精神薬の副作用への対処法】抗うつ薬による性機能障害
    小西 勇輝
    精神科, Sep. 2022
  • Prisoner's dilemma game in recovered schizophrenia patients, compared with healthy controls: Preliminary findings.
    Ryohei Igata; Hirofumi Tesen; Yuki Konishi; Atsuko Ikenouchi; Naomichi Okamoto; Reiji Yoshimura
    Schizophrenia research, May 2022
  • Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory Study.
    Naomichi Okamoto; Keita Watanabe; Hirofumi Tesen; Atsuko Ikenouchi; Ryohei Igata; Yuki Konishi; Tomoya Natsuyama; Rintaro Fujii; Shingo Kakeda; Taro Kishi; Nakao Iwata; Reiji Yoshimura
    Neurology international, Apr. 2022
  • Hippocampal Volume and Plasma Brain-Derived Neurotrophic Factor Levels in Patients With Depression and Healthy Controls.
    Rintaro Fujii; Keita Watanabe; Naomichi Okamoto; Tomoya Natsuyama; Hirofumi Tesen; Ryohei Igata; Yuki Konishi; Atsuko Ikenouchi; Shingo Kakeda; Reiji Yoshimura
    Frontiers in molecular neuroscience, 2022
  • Vortioxetine Improved Depressive State In Parkinson's Disease.
    Reiji Yoshimura; Atsuko Ikenouchi; Naomichi Okamoto; Yuki Konishi
    Cureus, Jun. 2021
  • Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram.
    Masamitsu Toshida; Yuki Konishi; Atsuko Ikenouchi; Naomichi Okamoto; Reiji Yoshimura
    Cureus, May 2021
  • Major depression with musical obsession treated with vortioxetine: a case report.
    Reiji Yoshimura; Naomichi Okamoto; Yuki Konishi; Atsuko Ikenouchi
    Annals of general psychiatry, Mar. 2021
  • Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings.
    Naomichi Okamoto; Koji Yoshino; Shogo Kitagawa; Rintaro Fujii; Shinsuke Hamada; Atsuko Ikenouchi; Yuki Konishi; Nobuhisa Ueda; Yoshinori Eto; Yasunari Tsutsumi; Reiji Yoshimura
    Frontiers in psychiatry, 2021
  • A Low Clozapine Dose Improved Refractory Tardive Dystonia without Exacerbating Psychiatric Symptoms: A Case Report.
    Naomichi Okamoto; Yuki Konishi; Hirofumi Tesen; Atsuko Ikenouchi; Reiji Yoshimura
    International medical case reports journal, 2021
  • A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine.
    Reiji Yoshimura; Atsuko Ikenouchi; Naomichi Okamoto; Yuki Konishi
    International medical case reports journal, 2021
  • Associations between plasma levels of C-reactive protein and catecholamine metabolites in patients with major depression.
    Reiji Yoshimura; Naomichi Okamoto; Yuki Konishi; Atsuko Ikenouchi
    Therapeutic advances in psychopharmacology, 2021
  • Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study.
    Naomichi Okamoto; Tomoya Natsuyama; Ryohei Igata; Yuki Konishi; Hirofumi Tesen; Atsuko Ikenouchi; Reiji Yoshimura
    Frontiers in psychiatry, 2021
  • Volume of Amygdala Subregions and Clinical Manifestations in Patients With First-Episode, Drug-Naïve Major Depression.
    Hirofumi Tesen; Keita Watanabe; Naomichi Okamoto; Atsuko Ikenouchi; Ryohei Igata; Yuki Konishi; Shingo Kakeda; Reiji Yoshimura
    Frontiers in human neuroscience, 2021
  • Panic Disorder Induced by the Coronavirus Disease Pandemic in a Patient with Organic Mood Disorder Successfully Treated with Vortioxetine.
    Reiji Yoshimura; Naomichi Okamoto; Yuki Konishi; Atsuko Ikenouchi
    Case reports in psychiatry, 2020
  • Efficacy of Electroconvulsive Therapy for Neuropathic Pain Comorbid with Major Depression.
    Masashi Ueda; Yuki Konishi; Kohei Sakurai; Atsuko Ikenouchi; Reiji Yoshimura
    Case reports in psychiatry, 2020
  • Effect of single caffeine intake on neuropsychological functions in healthy volunteers: A double-blind placebo-controlled study.
    Yuki Konishi; Hikaru Hori; Kenta Ide; Asuka Katsuki; Kiyokazu Atake; Ryohei Igata; Takamitsu Kubo; Hirotaka Tominaga; Hiroki Beppu; Toshio Asahara; Reiji Yoshimura
    PloS one, 2018
  • Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hikaru Hori; Reiji Yoshimura; Asuka Katsuki; Kiyokazu Atake; Ryohei Igata; Yuki Konishi; Jun Nakamura
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, Aug. 2017
  • Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia.
    Hikaru Hori; Reiji Yoshimura; Asuka Katsuki; Kiyokazu Atake; Ryohei Igata; Yuki Konishi; Hiroki Beppu; Hirotaka Tominaga
    International journal of molecular sciences, Mar. 2017
  • The Nursing Assessment of Medication Acceptance: the reliability and validity of a schizophrenia medication adherence scale.
    Hikaru Hori; Nobuhisa Ueda; Hideki Shiozuka; Ryohei Igata; Tazuko Miki; Kiyokazu Atake; Yuji Takeuchi; Hiroaki Shirozu; Naotoshi Ohara; Yuki Konishi; Hiroshi Nagai; Noriaki Sakurai; Takanori Kubota; Reiji Yoshimura
    Therapeutic advances in psychopharmacology, Jan. 2017
  • Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder.
    Reiji Yoshimura; Asuka Katsuki; Kiyokazu Atake; Hikaru Hori; Ryohei Igata; Yuki Konishi
    Neuropsychiatric disease and treatment, 2017
  • 健常者における神経認知機能に対するカフェイン単回投与の効果:プラセボ対照二重盲検比較試験
    小西 勇輝, 堀 輝, 井手 健太, 香月 あすか, 阿竹 聖和, 井形 亮平, 久保 隆光, 富永 裕崇, 別府 拓紀, 浅原 稔生, 吉村 玲児
    九州神経精神医学, Apr. 2020, Not reviewed, No invitation
    Lead, Corresponding
  • 私の論文から Effect of singli caffeine intake on neuropsychological functions in healthy volunteers: a double-blind placebo-controlled study.
    小西勇輝, 堀輝, 井手健太, 香月あすか, 阿竹聖和, 井形亮平, 久保隆光, 富永裕崇, 別府拓紀, 浅原稔生, 吉村玲児
    九州神経精神医学, Apr. 2019, Not reviewed, Invited
    Lead, Corresponding
  • 大人ADHDの見つけ方
    小西勇輝
    北九州市医報, May 2023, Not reviewed, Invited
    Lead, Corresponding
  • 特集ー職域における発達障害ー職域における発達障害への対応
    小西勇輝
    北九州市医報, Dec. 2021, Not reviewed, Invited
    Lead, Corresponding
  • 「コロナ禍で変わる職域のメンタルヘルス対応」 職域における神経発達症の労働者への対応
    小西勇輝
    日本社会精神医学会雑誌, Jan. 2024, Not reviewed, Invited
    Lead, Corresponding
  • 第31回日本産業精神保健学会 開催報告
    吉村玲児, 小西勇輝
    産業医学ジャーナル, Jan. 2025, Not reviewed, Invited
    Lead
  • 【精神疾患患者の就労・復職を支援する】気分障害を抱える労働者への休職・復職支援の現状と課題
    小西 勇輝
    精神医学, Mar. 2025, Not reviewed, Invited
    Lead, Corresponding
  • 【よく目にする向精神薬の副作用への対処法】抗うつ薬による性機能障害
    小西 勇輝
    精神科, Sep. 2022, Not reviewed, Invited
    Lead, Corresponding
  • 妊娠後期の統合失調感情障害合併妊婦に修正型電気けいれん療法を施行し経腟分娩した1例
    藤井 倫太郎, 古澤 隆太朗, 小西 勇輝, 池ノ内 篤子, 新開 隆弘, 吉村 玲児
    精神科, Aug. 2021, Reviewed, Invited
  • 【老年期精神神経疾患と神経炎症】老年期うつ病と炎症 インターロイキン-6(IL-6)を中心に
    星川 大, 小西 勇輝, 池ノ内 篤子, 吉村 玲児
    老年精神医学雑誌, Jul. 2020, Not reviewed, Invited
  • 【肝胆膵診療のNew Horizon】 膵疾患 急性膵炎 急性膵炎診療ガイドライン2010年第3版改訂の重要ポイント
    真弓 俊彦, 染谷 一貴, 山口 優子, 小西 勇輝, 高橋 直樹, 荒井 秀明, 長谷川 潤, 竹内 慶法, 大坪 広樹, 高間 辰雄, 鈴木 仁士, 城戸 貴志
    肝・胆・膵, Dec. 2014, Null, No invitation
  • 特集【薬物療法を上手く行うためのちょっとしたコツ】向精神薬による性機能障害とその対応-臨床現場での実践的アプローチ-
    小西勇輝
    臨床精神薬理, Jul. 2025, Not reviewed, Invited
    Lead, Corresponding
  • 【プライマリーケアでよく診る精神疾患】各種精神症状・疾患への対応 うつ病・双極性障害-診断と治療
    吉村 玲児, 小西 勇輝, 池ノ内 篤子
    臨牀と研究, Sep. 2020, Reviewed, Invited
  • Factors Influencing Continuing Employment Among Patients With Mood Disorders
    Hirofumi Tesen, Tomomi Matsumoto, Maiko Umezu, Kenta Ide, Koji Yoshino, Ryohei Igata, Yuki Konishi, Naomichi Okamoto, Atsuko Ikenouchi, Yoshihisa Fujino, and Reiji Yoshimura
    ASEAN Journal of Psychiatry, Aug. 2022, Reviewed, No invitation
  • Major depression with musical obsession treated with vortioxetine: a case report.
    Yoshimura Reiji, Okamoto Naomichi, Konishi Yuki, Ikenouchi Atsuko
    Annals of general psychiatry, Mar. 2021, Reviewed, No invitation
  • Association between salivary mature brain-derived neurotrophic factor and psychological distress in healthcare workers.
    Ikenouchi Atsuko, Okamoto Naomichi, Hamada Shinsuke, Chibaatar Enkhmurun, Fujii Rintaro, Konishi Yuki, Igata Ryohei, Tesen Hirofumi, Yoshimura Reiji
    Brain and behavior, Oct. 2023, Reviewed, No invitation
  • Panic Disorder Induced by the Coronavirus Disease Pandemic in a Patient with Organic Mood Disorder Successfully Treated with Vortioxetine.
    Yoshimura Reiji, Okamoto Naomichi, Konishi Yuki, Ikenouchi Atsuko
    Case reports in psychiatry, Oct. 2020, Not reviewed, No invitation
  • Efficacy of Electroconvulsive Therapy for Neuropathic Pain Comorbid with Major Depression.
    Ueda Masashi, Konishi Yuki, Sakurai Kohei, Ikenouchi Atsuko, Yoshimura Reiji
    Case reports in psychiatry, Dec. 2020, Reviewed, No invitation
  • Plasma levels of paroxetine are not associated with the increase of serum levels of brain-derived neurotrophic factor in major depression
    Reiji Yoshimura, Naomichi Okamoto, Yuki Konishi, Atsuko Ikenouchi
    Clinical Neuropsychopharmacology and Therapeutics, Jul. 2020, Reviewed, No invitation
  • Improvement of persistent cenesthopathy and depersonalization after treatment with brexpiprazole in schizophrenia
    Reiji Yoshimura, Atsuko Ikenouchi, Yuki Konishi
    Clinical Neuropsychopharmacology and Therapeutics, Jun. 2020, Reviewed, No invitation
    Last
  • Oromandibular Dystonia After Low-Dose Olanzapine Treatment in a Patient With Marchiafava-Bignami Disease With Demyelinating Lesions in the Corpus Callosum: A Case Report.
    Tsukada Nagiho, Okamoto Naomichi, Konishi Yuki, Ikenouchi Atsuko, Yoshimura Reiji
    Cureus, Jan. 2024, Null, No invitation
  • Vortioxetine Improved Depressive State In Parkinson's Disease.
    Yoshimura Reiji, Ikenouchi Atsuko, Okamoto Naomichi, Konishi Yuki
    Cureus, Jun. 2021, Reviewed, No invitation
    Last
  • Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram.
    Toshida Masamitsu, Konishi Yuki, Ikenouchi Atsuko, Okamoto Naomichi, Yoshimura Reiji
    Cureus, May 2021, Reviewed, No invitation
  • Serum levels of catecholamine metabolites and return to work in patients with major depression: preliminary study.
    Yoshimura R, Okamoto N, Konishi Y, Ikenouchi A
    The European Journal of Psychiatry, Aug. 2021, Reviewed, No invitation
  • Volume of Amygdala Subregions and Clinical Manifestations in Patients With First-Episode, Drug-Naïve Major Depression.
    Tesen Hirofumi, Watanabe Keita, Okamoto Naomichi, Ikenouchi Atsuko, Igata Ryohei, Konishi Yuki, Kakeda Shingo, Yoshimura Reiji
    Frontiers in human neuroscience, Jan. 2022, Reviewed, No invitation
  • Hippocampal Volume and Plasma Brain-Derived Neurotrophic Factor Levels in Patients With Depression and Healthy Controls.
    Fujii Rintaro, Watanabe Keita, Okamoto Naomichi, Natsuyama Tomoya, Tesen Hirofumi, Igata Ryohei, Konishi Yuki, Ikenouchi Atsuko, Kakeda Shingo, Yoshimura Reiji
    Frontiers in molecular neuroscience, May 2022, Reviewed, No invitation
  • Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study.
    Okamoto Naomichi, Natsuyama Tomoya, Igata Ryohei, Konishi Yuki, Tesen Hirofumi, Ikenouchi Atsuko, Yoshimura Reiji
    Frontiers in psychiatry, Jul. 2021, Reviewed, Invited
  • Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings.
    Okamoto Naomichi, Yoshino Koji, Kitagawa Shogo, Fujii Rintaro, Hamada Shinsuke, Ikenouchi Atsuko, Konishi Yuki, Ueda Nobuhisa, Eto Yoshinori, Tsutsumi Yasunari, Yoshimura Reiji
    Frontiers in psychiatry, Mar. 2021, Reviewed, No invitation
  • Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia.
    Hori Hikaru, Yoshimura Reiji, Katsuki Asuka, Atake Kiyokazu, Igata Ryohei, Konishi Yuki, Beppu Hiroki, Tominaga Hirotaka
    International journal of molecular sciences, Mar. 2017, Reviewed, Invited
  • A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine.
    Yoshimura Reiji, Ikenouchi Atsuko, Okamoto Naomichi, Konishi Yuki
    International medical case reports journal, Apr. 2021, Reviewed, No invitation
    Last
  • A Low Clozapine Dose Improved Refractory Tardive Dystonia without Exacerbating Psychiatric Symptoms: A Case Report.
    Okamoto Naomichi, Konishi Yuki, Tesen Hirofumi, Ikenouchi Atsuko, Yoshimura Reiji
    International medical case reports journal, Apr. 2021, Reviewed, No invitation
  • Can Plasma level of 3-methoxy-4-hydroxyphenylglycol Predict the Response for Selective Serotonin Reuptake Inhibitor and Serotonin Noradrenaline Reuptake Inhibitor in Major Depressive Disorder?
    Reiji Yoshimura, Asuka Katuki, Kiyokazu Atake, Ryohei Igata, Yuki Konishi, and Hikaru Hori
    Journal of Depression and Anxiety, Feb. 2017, Reviewed, No invitation
  • Plasma Levels of 3-Methoxy-4-Hydroxyphenylglycol and Relapse of Major Depressive Episode after Treatment with Milnacipran: one-Year Follow-Up Study
    Reiji Yoshimura, Asuka Katuki, Kiyokazu Atake, Hikaru Hori, Ryohei Igata and Yuki Konishi
    Journal of Depression and Anxiety, Nov. 2016, Reviewed, No invitation
    Last
  • Acute pancreatitis during valproic acid administration in a patient with vascular dementia, epileptic seizures, and psychiatric symptoms: a case report
    Mako Yanaga, Naomichi Okamoto, Reia Hashimoto, Ryohei Igata, Yuki Konishi, Atsuko Ikenouchi, Naoki Isomoto, Takahiro Shinkai, Masaru Harada, Reiji Yoshimura
    Journal of Medical Case Reports, May 2023, Reviewed, No invitation
  • Protocol for a Survey on the Impact of Caring for a Relative With Dementia on Caregivers' Health and Work Functioning.
    Ikenouchi Atsuko, Fujino Yoshihisa, Matsumoto Tomomi, Okamoto Naomichi, Hamada Shinsuke, Kitagawa Shogo, Maruyama Shunya, Konishi Yuki, Eguchi Hisashi, Yoshimura Reiji
    Journal of UOEH, Mar. 2025, Reviewed, No invitation
  • Comparison of Serum Metabolomics Pathways and Patterns between Patients with Major Depressive Disorder with and without Type 2 Diabetes Mellitus: An Exploratory Study.
    Okamoto Naomichi, Hoshikawa Takashi, Ikenouchi Atsuko, Natsuyama Tomoya, Fujii Rintaro, Igata Ryohei, Tesen Hirofumi, Konishi Yuki, Honma Yuichi, Harada Masaru, Yoshimura Reiji
    Journal of integrative neuroscience, Jan. 2023, Reviewed, No invitation
  • Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory Study.
    Okamoto Naomichi, Watanabe Keita, Tesen Hirofumi, Ikenouchi Atsuko, Igata Ryohei, Konishi Yuki, Natsuyama Tomoya, Fujii Rintaro, Kakeda Shingo, Kishi Taro, Iwata Nakao, Yoshimura Reiji
    Neurology international, Apr. 2022, Reviewed, No invitation
  • Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder.
    Yoshimura Reiji, Katsuki Asuka, Atake Kiyokazu, Hori Hikaru, Igata Ryohei, Konishi Yuki
    Neuropsychiatric disease and treatment, Feb. 2017, Reviewed, No invitation
    Last
  • Effects of frequently prescribed antiseizure medications on motor vehicle driving performance: Narrative review based on a tiered approach for the assessment of clinically meaningful driving impairment in the Ministry of Health, Labour, and Welfare guideline.
    Iwamoto Kunihiro, Nakabayashi Tetsuo, Yamaguchi Akiko, Konishi Yuki, Saji Momoe, Yoshimura Reiji, Kanemoto Kousuke, Aoki Hirofumi, Ando Masahiko, Ozaki Norio
    Neuropsychopharmacology reports, Dec. 2024, Reviewed, No invitation
  • Guideline for evaluating the effects of psychotropic drugs on motor vehicle driving performance in Japan: A tiered approach for the assessment of clinically meaningful driving impairment.
    Nakabayashi Tetsuo, Iwamoto Kunihiro, Yamaguchi Akiko, Konishi Yuki, Saji Momoe, Yoshimura Reiji, Kanemoto Kousuke, Aoki Hirofumi, Ando Masahiko, Ozaki Norio
    Neuropsychopharmacology reports, Jun. 2024, Reviewed, No invitation
  • The new guideline for evaluating effects of psychotropic drugs on the performance to drive a motor vehicle in Japan: Comparison with US FDA guideline.
    Iwamoto Kunihiro, Nakabayashi Tetsuo, Yamaguchi Akiko, Konishi Yuki, Saji Momoe, Yoshimura Reiji, Kanemoto Kousuke, Aoki Hirofumi, Ando Masahiko, Ozaki Norio
    Neuropsychopharmacology reports, Jun. 2023, Reviewed, No invitation
  • Effect of single caffeine intake on neuropsychological functions in healthy volunteers: A double-blind placebo-controlled study.
    Konishi Yuki, Hori Hikaru, Ide Kenta, Katsuki Asuka, Atake Kiyokazu, Igata Ryohei, Kubo Takamitsu, Tominaga Hirotaka, Beppu Hiroki, Asahara Toshio, Yoshimura Reiji
    PloS one, Oct. 2018, Reviewed, No invitation
    Lead
  • Isolated Adrenocorticotropic Hormone Deficiency accompanied by impaired cognitive function: A case report
    Atsuko Ikenouchi, Issei Seki, Naomichi Okamoto, Yuki Konishi, Reiji Yoshimura
    Psychiatry Research Case Reports, Sep. 2022, Reviewed, No invitation
  • Mania after long-term treatment with daily 10 mg prednisolone
    Rintaro Fujii, Yuki Konishi, Ryutaro Furusawa, Naomichi Okamoto, Reiji Yoshimura
    Psychiatry and clinical neurosciences Reports, Dec. 2022, Reviewed, No invitation
  • Low-dose lamotrigine induces Pisa syndrome in a patient with probable corticobasal degeneration despite previous use.
    Okamoto Naomichi, Sakakibara Takahiro, Tsukada Nagiho, Chibaatar Enkhmurun, Hayasaki Gaku, Konishi Yuki, Ikenouchi Atsuko, Yoshimura Reiji
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Nov. 2024, Reviewed, No invitation
  • A case of exploding head syndrome preceding the onset of mild cognitive impairment with Lewy bodies.
    Kitagawa Shogo, Okamoto Naomichi, Ikenouchi Atsuko, Igata Ryohei, Hashimoto Reia, Konishi Yuki, Tesen Hirofumi, Yoshimura Reiji
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, Jan. 2023, Reviewed, No invitation
  • Vortioxetine improved olfactory reference syndrome in a patient with major depressive disorder: A case report.
    Yoshimura R, Konishi Y, Okamoto N, Ikenouchi A
    Revista de Psiquiatria Clinica, Jul. 2021, Reviewed, No invitation
  • Plasma paroxetine level is independent of the change in plasma interleukin-6 level in remitted patients with major depressive disorder.
    Yoshimura R, Okamoto N, Konishi Y, Ikenouchi A
    Revista de Psiquiatria Clinica, Jul. 2021, Reviewed, No invitation
  • Oral Cenesthopathy Proceeding Dementia with Lewy Body: a Case Report
    Yuta Sawada, Yuki Konishi, Atsuko Ikenouchi, Reiji Yoshimura1
    SN Comprehensive Clinical Medicine, Feb. 2021, Reviewed, No invitation
  • Prisoner's dilemma game in recovered schizophrenia patients, compared with healthy controls: Preliminary findings.
    Igata Ryohei, Tesen Hirofumi, Konishi Yuki, Ikenouchi Atsuko, Okamoto Naomichi, Yoshimura Reiji
    Schizophrenia research, Jul. 2021, Reviewed, No invitation
  • Associations between plasma levels of C-reactive protein and catecholamine metabolites in patients with major depression
    Reiji Yoshimura, Naomichi Okamoto, Yuki Konishi and Atsuko Ikenouchi
    Therapeutic Advances in Psychopharmacology, May 2021, Reviewed, No invitation
  • The Nursing Assessment of Medication Acceptance: the reliability and validity of a schizophrenia medication adherence scale.
    Hori Hikaru, Ueda Nobuhisa, Shiozuka Hideki, Igata Ryohei, Miki Tazuko, Atake Kiyokazu, Takeuchi Yuji, Shirozu Hiroaki, Ohara Naotoshi, Konishi Yuki, Nagai Hiroshi, Sakurai Noriaki, Kubota Takanori, Yoshimura Reiji
    Therapeutic advances in psychopharmacology, Jan. 2017, Reviewed, No invitation
  • PCLO rs2522833-mediated gray matter volume reduction in patients with drug-naive, first-episode major depressive disorder.
    Igata R, Katsuki A, Kakeda S, Watanabe K, Igata N, Hori H, Konishi Y, Atake K, Kawasaki Y, Korogi Y, Yoshimura R
    Translational psychiatry, May 2017, Reviewed, No invitation
  • Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hori Hikaru, Yoshimura Reiji, Katsuki Asuka, Atake Kiyokazu, Igata Ryohei, Konishi Yuki, Nakamura Jun
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, Aug. 2016, Reviewed, No invitation